Adamas to Present at Upcoming June Conferences
27 Mayo 2021 - 3:11PM
Business Wire
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated
to developing and delivering medicines that make a meaningful
difference to people affected by neurological diseases, today
announced that the organization will be participating in two
upcoming June conferences:
- Christopher B. Prentiss, Chief Financial Officer will present
at the William Blair 41st Annual Growth Stock Conference on
Thursday, June 3 2021 at 11:00 am Eastern Time.
- Neil F. McFarlane, Chief Executive Officer will participate in
a fireside chat at the JMP Securities Life Sciences Conference on
Wednesday, June 16 at 3:30 pm Eastern Time.
Both the presentation and the fireside chat will be broadcast
live from the investor relations section of the Adamas website at
http://ir.adamaspharma.com/events-presentations. Replays of the
events will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines
that reduce the burden of neurological diseases on patients,
caregivers and, society. We are a fully-integrated company focused
on growing a portfolio of therapies to address a range of
neurological diseases. For more information, please visit
www.adamaspharma.com.
Source: Adamas Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210527005789/en/
Media: Sarah Mathieson Vice President, Corporate Communications
510-450-3528 smathieson@adamaspharma.com
Investors: Peter Vozzo Managing Director Westwicke/ICR
443-213-0505 peter.vozzo@westwicke.com
Adamas Pharmaceuticals (NASDAQ:ADMS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adamas Pharmaceuticals (NASDAQ:ADMS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Adamas Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Adamas Pharmaceuticals, Inc. Artículos de Noticias